Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
1
11%
Ph phase_4
2
22%
Ph early_phase_1
1
11%
Ph phase_2
1
11%
Ph not_applicable
4
44%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown1
Withdrawn1
Not yet recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 31 (11.1%)
Phase 42 (22.2%)
N/A4 (44.4%)

Trials by Status

unknown111%
withdrawn111%
completed556%
not_yet_recruiting111%
suspended111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9